Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Quantum Cyber ( (QUCY) ) has provided an announcement.
On February 13, 2026, Quantum Cyber entered into a $6 million private placement with investor David E. Lazar, issuing series A, B and C preferred shares on February 17, 2026 for $3 million and completing the second closing for series D and E preferred shares on April 22, 2026 after a prepayment in March. The second tranche, representing over 90% of the company’s fully diluted ordinary share base at issuance, was sold under Securities Act exemptions and materially concentrates ownership while enabling substantial potential dilution to existing shareholders.
At an April 22, 2026 Extraordinary General Meeting, shareholders approved wide-ranging measures including new share issuances, amendments to the Articles of Association, a reverse stock split framework, and expansion of the 2025 Omnibus Incentive Plan, alongside confirming board resolutions and auditor appointment flexibility. The same day, the company changed its name to Quantum Cyber N.V., revamped its board and committee structure by appointing David Natan and Avraham Ben‑Tzvi and accepting four director and one co‑CEO resignations, consolidating governance under a new leadership slate with deep capital markets and governance expertise.
The most recent analyst rating on (QUCY) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Quantum Cyber stock, see the QUCY Stock Forecast page.
Spark’s Take on QUCY Stock
According to Spark, TipRanks’ AI Analyst, QUCY is a Neutral.
The score is primarily constrained by weak financial performance, including persistent losses, negative operating cash flow, and high leverage. Technicals offer only modest support with short-term improvement but a longer-term downtrend. Valuation impact is neutral due to missing P/E and dividend yield data.
To see Spark’s full report on QUCY stock, click here.
More about Quantum Cyber
Quantum Cyber N.V., formerly Mainz Biomed N.V., is listed on the Nasdaq Capital Market under the ticker QUCY and has expanded its authorized capital to 900 million ordinary shares and 100 million preferred shares across five series. The rebranding and large increase in authorized equity suggest a strategic pivot and capital-raising focus that could significantly reshape its shareholder base and future financing capacity.
Average Trading Volume: 675,313
Technical Sentiment Signal: Sell
Current Market Cap: $6.35M
Learn more about QUCY stock on TipRanks’ Stock Analysis page.